The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*
Abstract
OBJECTIVES: There has long-been controversy about the possible superiority of norepinephrine compared to dopamine in the treatment of shock. The objective was to evaluate the effects of norepinephrine and dopamine on outcome and adverse events in patients with septic shock. DATA SOURCES: A systematic search of the MEDLINE, Embase, Scopus, and CENTRAL databases, and of Google Scholar, up to June 30, 2011. STUDY SELECTION AND DATA EXTRACTION: All studies providing information on the outcome of patients with septic shock treated with dopamine compared to norepinephrine were included. Observational and randomized trials were analyzed separately. Because time of outcome assessment varied among trials, we evaluated 28-day mortality or closest estimate. Heterogeneity among trials was assessed using the Cochrane Q homogeneity test. A Forest plot was constructed and the aggregate relative risk of death was computed. Potential publication bias was evaluated using funnel plots. METHODS AND MAIN RESULTS: We retrieved five observational (1,360 patients) and six randomized (1,408 patients) trials, totaling 2,768 patients (1,474 who received norepinephrine and 1,294 who received dopamine). In observational studies, among which there was significant heterogeneity (p < .001), there was no difference in mortality (relative risk, 1.09; confidence interval, 0.84-1.41; p = .72). A sensitivity analysis identified one trial as being responsible for the heterogeneity; after exclusion of that trial, no heterogeneity was observed and dopamine administration was associated with an increased risk of death (relative risk, 1.23; confidence interval, 1.05-1.43; p < .01). In randomized trials, for which no heterogeneity or publication bias was detected (p = .77), dopamine was associated with an increased risk of death (relative risk, 1.12; confidence interval, 1.01-1.20; p = .035). In the two trials that reported arrhythmias, these were more frequent with dopamine than with norepinephrine (relative risk, 2.34; confidence interval, 1.46-3.77; p = .001). CONCLUSIONS: In patients with septic shock, dopamine administration is associated with greater mortality and a higher incidence of arrhythmic events compared to norepinephrine administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationComparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Self-citationLow-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial
(2000) · The Lancet · doi:10.1016/s0140-6736(00)03495-4 · Cited by 997
Müllner, M., Urbanek, B., Havel, C., Losert, H., Gamper, G., & Herkner, H. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub2 · Cited by 654
Hemodynamic variables related to outcome in septic shock
Varpula, M., Tallgren, M., Saukkonen, K., Voipio-Pulkki, L.-M., & Pettilä, V. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2688-z · Cited by 555
van der Poll, T., Coyle, S. M., Barbosa, K., Braxton, C. C., & Lowry, S. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118469 · Cited by 519
Norepinephrine or Dopamine for the Treatment of Hyperdynamic Septic Shock?
Martin, C., Papazian, L., Perrin, G., Saux, P., & Gouin, F. (1993) · Chest · doi:10.1378/chest.103.6.1826 · Cited by 460
Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
(1999) · Critical Care Medicine · doi:10.1097/00003246-199903000-00049 · Cited by 438
Sakr, Y., Reinhart, K., Vincent, J.-L., Sprung, C. L., Moreno, R., Ranieri, V. M., De Backer, D., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201896.45809.e3 · Cited by 404
Self-citationMarik, P. E. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520170064037 · Cited by 401
Effect of norepinephrine on the outcome of septic shock
Martin, C., Viviand, X., Leone, M., & Thirion, X. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00012 · Cited by 366
Regional blood flow and oxygen transport in septic shock
BUOKONEN, E., TAKALA, J., KARI, A., SAXÉN, H., MERTSOLA, J., & HANSEN, E. J. J. (1993) · Critical Care Medicine · doi:10.1097/00003246-199309000-00011 · Cited by 360
Anterior pituitary function during critical illness and dopamine treatment
Van den Berghe, G., & de Zegher, F. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00024 · Cited by 256
Vasopressors for hypotensive shock
Gamper, G., Havel, C., Arrich, J., Losert, H., Pace, N. L., Müllner, M., & Herkner, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub4 · Cited by 239
EFFICACY AND SAFETY OF DOPAMINE VERSUS NOREPINEPHRINE IN THE MANAGEMENT OF SEPTIC SHOCK
Patel, G. P., Grahe, J. J. S., Sperry, M., Singla, S., Elpern, E. H., Lateef, O., & BALK, R. A. (2010) · Shock · doi:10.1097/shk.0b013e3181c6ba6f · Cited by 141
Norepinephrine or Dopamine for Septic Shock: Systematic Review of Randomized Clinical Trials
Vasu, T. S., Cavallazzi, R., Hirani, A., Kaplan, G., Leiby, B. E., & Marik, P. E. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066610396312 · Cited by 122
Hemodynamic support in septic shock
Vincent, J. (2001) · Intensive Care Medicine · doi:10.1007/pl00003799 · Cited by 108
Self-citationThe significance of non-sustained hypotension in emergency department patients with sepsis
Marchick, M. R., Kline, J. A., & Jones, A. E. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1448-x · Cited by 86
Póvoa, P. M. S. R., Carneiro, A., Ribeiro, O., & Costa‐Pereira, A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181958b1c · Cited by 73
Lévy, B., Dusang, B., Annane, D., Gibot, S., & Bollaert, P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181297.14319.3c · Cited by 60
Early and exclusive use of norepinephrine in septic shock
Morimatsu, H., Singh, K., Uchino, S., Bellomo, R., & Hart, G. K. (2004) · Resuscitation · doi:10.1016/j.resuscitation.2004.03.016 · Cited by 51
Chakraborty, A., Mathur, S. K., & Dhunna, R. (2007) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.37713 · Cited by 22
Dopamine therapy in septic shock: Detrimental effect on survival?
Boulain, T., Runge, I., Bercault, N., Benzékri-Lefèvre, D., Wolf, M., & Fleury, C. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.11.003 · Cited by 22
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationThe Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“A network meta-analysis resulted in imprecise estimates (wide confidence intervals) when phenylephrine was compared to other vasopressors (281).”
Self-citationSevere Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Metadata
- Authors
- De Backer, D., Aldecoa, C., Njimi, H., & Vincent, J.-L.
- Venue
- Critical Care Medicine
- Published
- 2012-03
- Volume
- 40
- Issue
- 3
- Pages
- 725-730
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2029411057
- Cited by
- 389
- References
- 31
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.